Will it be reported that Joe Biden used Ambien before the 2024 presidential debate?

Claims regarding Joe Biden's Ambien use emerged, but remain unverified. Hunter Biden stated on July 21–22, 2025, that Joe Biden was given Ambien to sleep during extensive travel, suggesting it contributed to his poor June 27, 2024 debate performance ^[1][2][3][4]. Hunter Biden subsequently clarified to ABC News that he did not assert his father took Ambien immediately before the debate, stating he did not know whether Biden used it in the weeks beforehand ^[2]. The claim remains unverified; reporting identified no medical records, prescription documentation, or independent confirmation ^[5][3]. A medical expert noted that if Ambien were taken the night before, its effects would generally dissipate by the time of the debate ^[3]. Biden's established explanation for his debate struggles was exhaustion or jet lag following overseas travel, despite several days of debate preparation at Camp David, a performance that triggered pressure leading him to withdraw from the 2024 race on July 21, 2024 ^[1][4].

Market resolution depends on precise reporting criteria, with varied trading activity. The relevant contract resolves January 1, 2028, and asks whether qualifying reporting by designated source agencies occurs before then ^[6]. Market snapshots vary; the indexed page showed 0% chance and no volume, while third-party trackers reported approximately 19% Yes on September 28, 2026, and 24% Yes / 76% No on September 27, 2026, indicating thin or changing liquidity and inconsistent snapshots ^[6][7][8]. Later discussion in 2026 broadened the speculation, with Jill Biden reportedly wondering whether Joe Biden could have taken Ambien or codeine cough syrup while ill; however, she framed this as uncertainty, not evidence ^[9][10]. Prior to the debate, Washington Post analysis cited experts stating no drug could temporarily mask cognitive decline, but that discussion did not establish or disprove Ambien use ^[11].

Further reporting is plausible, but definitive proof for settlement is uncertain. The market focuses on whether qualifying reporting occurs, not whether Ambien use is medically proven ^{[6][7][8][12][13]}. While initial major-news reports about Hunter Biden's claims already exist, settlement is rule-dependent, as the contract's language may require reporting by specifically designated source agencies and could distinguish a source's claim from independently verified reporting ^{[6][7][8][12][13]}. Additional reporting before 2028 is plausible because the issue has resurfaced through Hunter Biden and Jill Biden ^{[1][5][2][9][10]}. However, definitive confirmation is less likely without medical records, contemporaneous staff testimony, or prescription evidence ^{[1][5][2][9][10]}. Key dates include the June 27, 2024 debate, Biden's July 21, 2024 campaign withdrawal, Hunter's July 21, 2025 interview and related reporting, and the January 1, 2028 market resolution deadline ^{[1][2][9][10]}.